NIH Guidelines

Commonly referred to as clinical or professional guidelines, the National Institutes of Health pubHsh physician guidelines for the most common diseases. Publications are available at the following by relevant Institute  

National Institutes of Health (NIH) guidelines consolidated across agencies available at httpv/health.nih.gov/ 

National Institute of General Medical Sciences (NIGMS) fact sheets available at httpvywww.nigms.iiih.gov/Publicatioiis/FactSheets.htm 

National Library of Medicine (NLM) extensive encyclopedia (A.D.A.M., Inc.) with guidelines httpvywww.nlm.nih.gov/medlineplu ealthtopics.html 

National Gancer Institute (NGI) guidelines available at httpvywww.cancer.gov/cancertopics/pdq 

Commonly referred to as clinical or professional guidelines, the National Institutes of 

Health publish physician guidelines for the most common diseases. Publications are 

8 These publications are typically written by one or more of the various NIH Institutes. 

---

Refer to NIH pubhcation no. 85-23, Guide for the Care and Use of Laboratory Animals-, NIH publication no. 81-2385, NIH Guidelines for the Laboratory Use of Chemical Carcinogens-, and the Pubhc Health Service s Biosafety Guidelines for Microbiological and Biomedical Laboratories for additional discussion of these issues. 

National Institutes of Health (NIH) (1994) NIH guidelines on the inclusion of women and minorities as subjects in clinical research. NIH Guide, March 18, 1994 (also available at http //grants.nih. gov/grants/funding/women min/guidelines update.htm). 

NIFI (2002), Guidelines for research involving recombinant DNA molecules. Available at http //www4.od.nih.gov/oba/rac/guidelines 02/nih guidelines apr 02.htm... 

Cancer Institute, Office of Research Safety. Laboratory safety monograph - a supplement to the NIH guidelines for recombinant DNA research. Bethesda, MD 20014. 1978. 

Centers or Disease Control-NIH guidelines (HHS publication [CDC] 93-8395) specify the use of BS level II containment for work with infectious HBV. Vaccination of all laboratory personnel is also recommended. 

The NIH guidelines were originally developed to cover microbiological research carried out in a laboratory environment. 

In response to a request by scientists, the National Institutes of Health (NIH) established the NIH Recombinant DNA Advisory Committee (RAC) and the NIH Guidelines for Research Involving Recombinant DNA Molecules these Guidelines, first issued in 1976, and revised many times since then, are safety standards for recombinant DNA work, including agricultural experiments and field tests. 

The original 1976 NIH Guidelines included a list of types of experiments that were "not to be initiated at the present time."... 

After their promulgation in 1976, the NIH Guidelines were adopted by other Federal agencies including the Department of Agriculture. 

The first revision of the NIH Guidelines was issued in December 1978 (14). Some of the major changes in the December 1978 Guidelines, as compared with the original, were ... 

USDA therefore concluded in its Policy Statement that "the existing regulatory framework of USDA combined with NIH Guidelines. .. are adequate and appropriate for regulatory research, development, testing and evaluation, production and application of these biotechnology [derived] products."... 

NIH Guidelines for Research Involving Recombinant DMA Molecules", Federal Register, July 7, 1976, Part 11, 27902-27943. Berg, P. Ambio 1977, 6, 253-260. 

---